INS and type 2 diabetes mellitus: We hypothesized that autologous bone marrow-derived mononuclear cells (ABM-MNCs) in patients with T2DM would lead to decrease in insulin requirement with sustained euglycemia and this may be modulated through either improvement in β-cell function or insulin sensitivity or both.